Bipolar disorder, Personality disorders and Technology

Introducing the Borderline Personality Disorder Inventory

Psychiatric Times

JUNE 25, 2025

SHOW MORE Discover the innovative Borderline Personality Disorder Inventory (BPD-I™), a psychodynamically-informed tool for assessing BPD symptoms effectively. Наталья Добровольска/AdobeStock Borderline personality disorder (BPD) remains one of the most commonly misunderstood and challenging diagnoses in mental health.

Personality disorders

Personality disorders Sleep and mental health Bipolar disorder Eating disorders

Eyes, Ears, and Emotion: Techniques to Tackle Diagnosing Bipolar Disorder

Psychiatric Times

JULY 14, 2025

Emerging research on RNA biomarkers, AI applications, and genetic mutations shows promise for developing new diagnostic tools for bipolar disorder. Non-pharmacological approaches and combination therapies are emphasized in treatment, with recent FDA approvals for new medications targeting bipolar symptoms.

Bipolar disorder

Bipolar disorder Genetics and mental health Sleep and mental health Eating disorders

Exploring NMDA Antagonists for MDD

Psychiatric Times

JULY 11, 2025

Leah Kuntz October 7th 2021 Blue Light Blockers: A Behavior Therapy for Mania Chris Aiken, MD Kellie Newsome, PMH-NP July 7th 2025 Transformation 2.0: The GLP-1 RAs as Psychiatric Medications? Leah Kuntz October 7th 2021 Blue Light Blockers: A Behavior Therapy for Mania Chris Aiken, MD Kellie Newsome, PMH-NP July 7th 2025 Transformation 2.0:

Bipolar disorder

Bipolar disorder Sleep and mental health Eating disorders Technology

The Psychiatric Pipeline in Review: Quarter 2, 2025

Psychiatric Times

JULY 7, 2025

Trontinemab showed significant amyloid plaque reduction in Alzheimer's, validating Brainshuttle technology and prompting a phase 3 study. MindMed initiated a phase 3 study of MM120 for major depressive disorder, with results expected in the second half of 2026. Results are expected in 2026.

Pharmaceuticals

Pharmaceuticals Sleep and mental health Genetics and mental health Technology

Gerald Maguire, MD, Provides Tips for Differentiating Bipolar Depression From MDD

Psychiatric Times

JULY 11, 2025

Similarly, because patients with bipolar disorder often self-medicate, looking for a family history of substance abuse can be helpful. “iI's Family histories can also support the differential diagnosis , he said. For instance, if there is a family history of suicides, that may be a clue, he explained.

Bipolar disorder

Bipolar disorder Sleep and mental health Eating disorders Self-awareness

sNDA Submitted: Lumateperone for the Prevention of Relapse in Schizophrenia

Psychiatric Times

JULY 8, 2025

News Media Peer Exchange Case-Based Psych Perspectives Clinical Case Collective Insights Peers & Perspectives Slideshows Videos Conferences Conference Coverage Conference Listing Publication Psychiatric Times Job Board CME/CE Partners Editorial Resources Between the Lines Expert Perspectives Clinical Consult Clinical Scales Interactive Tools Partner (..)

Introducing the Borderline Personality Disorder Inventory

Eyes, Ears, and Emotion: Techniques to Tackle Diagnosing Bipolar Disorder

Trending Sources

Exploring NMDA Antagonists for MDD

The Psychiatric Pipeline in Review: Quarter 2, 2025

Gerald Maguire, MD, Provides Tips for Differentiating Bipolar Depression From MDD

sNDA Submitted: Lumateperone for the Prevention of Relapse in Schizophrenia

FDA Requires New Label Warning of Weight Loss Risk in Pediatric Patients Taking Extended-Release Stimulants for ADHD

COMP360 Psilocybin for Treatment-Resistant Depression: Positive Phase 3 Efficacy Data

Tardive Dyskinesia: Treat Functional Impairment, Not the AIMS Score

Using Serum Drug Levels

The 2025 Summer Heatwave: Implications for Patients With Psychiatric Disorders

PTSD Is Treatable, But There's No Holy Grail: Insights From Arash Javanbakht, MD

Are You Ready for the Southern California Psychiatry Conference?

FDA Advisory Committee Votes Against Recommending Brexpiprazole Plus Sertraline for PTSD

Intergenerational Gaps and the Role of Technology in Psychiatric Leadership: A Trainee’s Perspective

Brief Book Reviews: July 2025

How Do Psychiatry Residents Learn Psychopharmacology?

ADHD Treatment Options

Major Depressive Disorder Research Roundup: July 25, 2025

TSND-201 Receives Breakthrough Therapy Designation From FDA for PTSD

June in Review: Updates on the Psychiatric Treatment Pipeline

Nonstimulant Therapies for ADHD

Successfully Prescribing MAOIs for Depression

The 6 Steps to Catalyze CBT and DBT With Young Patients

PTSD In Review: Treatment Insights

NRx Pharmaceuticals Applies for FDA National Priority Voucher for Intravenous Ketamine (NRX-100)

Risk Factors for ADHD

Key Issues in Postpartum Psychiatry at Southern California Conference

99 Pubs and Zero Followers? Psychiatric Leadership in the Age of Influencers

Ode to Foresight

Advancing PTSD Treatment: What's Taken So Long?

What Is a Sleep Disorder? A Harmful Dysfunction Analysis

Clinical Pearls in Prescribing Medications for Perinatal Patients

Will Retirement of Mental Health Professionals Escalate?

Redemption in Psychiatry

Ode to Self-Compassion

Redemption in Psychiatry, Part 2: Collegial Reactions

Prodromal Symptoms of Schizophrenia: Understanding and Addressing Challenges

Reporting From Canada, #1: Have Americans Turned Into Zombies?

Reduced Parahippocampal Volume Found to Be Related to Major Depressive Disorder in Study Using 7T MRI

Walking the Line: Navigating Student Mistreatment by Patients

Rexulti in Combination With Sertraline for PTSD: Upcoming FDA Advisory Committee Discussion

Grandparents and Grandchildren: A Psychiatrist and His Granddaughter Share Their Relationship Implications for Mental Health

Transformation 2.0: The GLP-1 RAs as Psychiatric Medications?

Stay Connected